Dear Lil,
May I just add one thing to this form of treatment, Topotecan. For those
who are on Coumadin or Warfarin, a blood thinner, Topotecan is one of
those chemotherapies one must be concerned as Topotecan drives down all
the blood cells quite rapidly, red, white and platelets and the
combination between Topotecan and the blood thinner reacts in such a way
as to cause, in many, spontaneous bleeding and hematomas. That happened
with Barb last July both in her brain and her spine. So one has to be
cautious when taking this combination of treatments. Just adding my two
cents worth from experience. Thanks Lil for letting me add something
here.
God Bless You All,
marty
> Lillian wrote:
>
> PHILADELPHIA, PA -- February 29, 2000 -- New study results demonstrate
> that one-third of patients with recurrent ovarian cancer who
> >are categorized as platinum-sensitive respond to treatment with
> Hycamtin(R) (topotecan hydrochloride for injection). The multicenter
> >study, conducted by the Gynecologic Oncology Group (GOG) and
> published this week in the March issue of the Journal of Clinical
> >Oncology, is the first to evaluate the efficacy of Hycamtin
> specifically in the platinum-sensitive patient population (defined as
> >those patients who experience a relapse six or more months after
> prior treatment).
> >
> > http://www.pslgroup.com/dg/1780fe.htm
> ----------------------------------------------------------------------
> Warmly, lillian
>
> We invite you to take a look at our
> Album.
> www.angelfire.com/sc/molangels/index.html
>
> ( Very informational, good tips, Molers pictures, art work and much
> more....
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
